1. Home
  2. HBNC vs CBLL Comparison

HBNC vs CBLL Comparison

Compare HBNC & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Horizon Bancorp Inc.

HBNC

Horizon Bancorp Inc.

HOLD

Current Price

$17.69

Market Cap

883.5M

Sector

Finance

ML Signal

HOLD

Logo CeriBell Inc.

CBLL

CeriBell Inc.

HOLD

Current Price

$17.99

Market Cap

750.1M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
HBNC
CBLL
Founded
1873
2014
Country
United States
United States
Employees
N/A
280
Industry
Major Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
883.5M
750.1M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
HBNC
CBLL
Price
$17.69
$17.99
Analyst Decision
Buy
Strong Buy
Analyst Count
4
6
Target Price
$20.25
$24.67
AVG Volume (30 Days)
285.7K
258.4K
Earning Date
04-22-2026
05-07-2026
Dividend Yield
3.63%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$29.57
Revenue Next Year
$5.14
$28.44
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.71
$10.85
52 Week High
$19.07
$24.33

Technical Indicators

Market Signals
Indicator
HBNC
CBLL
Relative Strength Index (RSI) 69.03 44.57
Support Level $15.69 $17.05
Resistance Level $18.87 $19.97
Average True Range (ATR) 0.42 0.71
MACD 0.21 0.04
Stochastic Oscillator 96.92 23.35

Price Performance

Historical Comparison
HBNC
CBLL

About HBNC Horizon Bancorp Inc.

Horizon Bancorp (IN) is a United States-based holding company providing banking services. It is engaged in providing commercial and retail banking services, corporate and individual trust and agency services, and other services incident to banking. The company also provides commercial loans, real estate loans, mortgage warehouse loans, consumer loans, and other credit facilities. The company has one principal business segment, commercial banking.

About CBLL CeriBell Inc.

CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.

Share on Social Networks: